Run don't walk to Portal Playground at Bayer Co.Lab Roof Deck! Chicken sandwiches🐔, delish sides🍟 and drinks🍻 will be served. Registration required: https://lu.ma/gs7ptchr
About us
Portal is a cell engineering platform company focused on enabling next generation cell engineering and cell analytics across research and clinical applications. We are implementing a simplified approach to intracellular delivery, focused on accelerating advances enabled by the new generation of RNA, gene editing, and AI-driven technologies. Portal’s initial product suite is based on a proprietary mechanical delivery system capable of delivering many different types of cargo to a broad range of cell types. The technology's ability to be used stand-alone or as an integrated component of third-party systems provides a significant opportunity to broadly impact the fields of biological research and cellular therapeutics
- Website
-
https://portal.bio/
External link for Portal
- Industry
- Biotechnology Research
- Company size
- 2-10 employees
- Headquarters
- Watertown, Massachusetts
- Type
- Privately Held
- Founded
- 2023
Locations
-
Primary
134 Coolidge Ave
Watertown, Massachusetts 02472, US
Employees at Portal
Updates
-
Impermeable no more! Swing by Jacquelyn Sikora Hanson, Ph.D.'s poster highlighting Portal's powers in drug discovery at Discovery on Target.
-
While #radiation from external sources has been used in #cancer treatment for many years, an increasingly popular modality involves radiotherapeutics where radioactive particles and a targeting element are injected directly into patients. They have some compelling advantages but can be complex to supply and administer. #cellstories by Armon Sharei and Shirley Mao. Past episodes: rvnway.com/cellstories
-
+1
-
We're 1 week out from Armon Sharei, PhD (Founder and CEO, Portal) and Eddie Eltoukhy (Partner, Pear VC) boba-fueled chat at Stanford University on how Armon went from PhD to IPO! Register here: https://lu.ma/1ysna29e
-
Make your cells better inspectors! Chat with Jacquelyn Sikora Hanson, Ph.D. and Crystal Tsui at Discovery on Target next week!
-
Portal reposted this
This blog highlights our collaboration with Portal Biotechnologies to develop a protocol for the high-efficiency loading of Mesenchymal Stem Cells (MSCs) with diverse cargo while maintaining their key Critical Quality Attributes. For #advancedtherapy product developers, the common barrier of low transfection efficiency is overcome through a combination of RoosterBio MSCs and #geneticengineering media with Portal’s Gateway™ high-efficiency cargo loading system. Learn more: https://lnkd.in/eykQP_Fm #celltherapy #cellandgenetherapy #stemcelltherapy #exosomes
-
Portal reposted this
Run don't walk to Portal Playground at Bayer Co.Lab Roof Deck! Chicken sandwiches🐔, delish sides🍟 and drinks🍻 will be served. Registration required: https://lu.ma/gs7ptchr
-
Join us at Portal Playground for fun, games and beer garden vibes on September 16th! RSVP Required: https://lu.ma/gs7ptchr
-
Roof Deck Party! Join us for fun and games at Portal Playground on Sept 16th at Bayer Co.Lab Cambridge. Register: https://lu.ma/gs7ptchr
-
Boosting >1 Billion cells! Our white paper with ScaleReady demonstrates robust CRISPR editing and mRNA expression with Portal's clinical boosters! https://lnkd.in/epTHwX75